Literature DB >> 32528900

Caspofungin Induced Cell Wall Changes of Candida Species Influences Macrophage Interactions.

Louise A Walker1, Carol A Munro1.   

Abstract

Candida species are known to differ in their ability to cause infection and have been shown to display varied susceptibilities to antifungal drugs. Treatment with the echinocandin, caspofungin, leads to compensatory alterations in the fungal cell wall. This study was performed to compare the structure and composition of the cell walls of different Candida species alone and in response to caspofungin treatment, and to evaluate how changes at the fungal cell surface affects interactions with macrophages. We demonstrated that the length of the outer fibrillar layer varied between Candida species and that, in most cases, reduced fibril length correlated with increased exposure of β-1,3-glucan on the cell surface. Candida glabrata and Candida guilliermondii, which had naturally more β-1,3-glucan exposed on the cell surface, were phagocytosed significantly more efficiently by J774 macrophages. Treatment with caspofungin resulted in increased exposure of chitin and β-1,3-glucan on the surface of the majority of Candida species isolates that were tested, with the exception of C. glabrata and Candida parapsilosis isolates. This increase in exposure of the inner cell wall polysaccharides, in most cases, correlated with reduced uptake by macrophages and in turn, a decrease in production of TNFα. Here we show that differences in the exposure of cell wall carbohydrates and variations in the repertoire of covalently attached surface proteins of different Candida species contributes to their recognition by immune cells.
Copyright © 2020 Walker and Munro.

Entities:  

Keywords:  3-glucan; GPI-anchored proteins; chitin; echinocandin; fungal cell wall; immune response; macrophages; β-1

Mesh:

Substances:

Year:  2020        PMID: 32528900      PMCID: PMC7247809          DOI: 10.3389/fcimb.2020.00164

Source DB:  PubMed          Journal:  Front Cell Infect Microbiol        ISSN: 2235-2988            Impact factor:   5.293


Introduction

Candida species differ in their ability to cause infection. Candida albicans is the most common cause of Candida bloodstream infections (40%), followed by Candida glabrata (29%), Candida parapsilosis (11%), Candida tropicalis (4%), Candida dubliniensis (2%), and Candida lusitaniae (<1%) (Data captured from England; Health Protection Report, 2018). Candida species also have varied susceptibilities to antifungal drugs. The echinocandins act by specifically inhibiting the synthesis of β-1,3-glucan in the fungal cell wall. The inhibition of β-1,3-glucan synthesis occurs predominantly through inhibition of the catalytic Fks glucan synthase subunits (Kurtz and Douglas, 1997). Caspofungin is one of the most widely used of the echinocandins in the clinic and has fungicidal activity against the majority of Candida species. C. lusitaniae, C. parapsilosis, and Candida guilliermondii are known to have relatively reduced susceptibility compared to C. albicans and in recent years the incidence of clinical isolates of C. glabrata, which have acquired resistance to the echinocandins has increased (Garcia-Effron et al., 2010; Pfaller et al., 2013). Alarmingly echinocandin-resistant C. glabrata isolates (up to 38%) were also cross-resistant to fluconazole (Pfaller et al., 2012, 2013). Acquired resistance is predominantly mediated by point mutations within hotspot regions in the FKS genes (Park et al., 2005; Balashov et al., 2006; Garcia-Effron et al., 2010; Alexander et al., 2013; Pham et al., 2014; Marti-Carrizosa et al., 2015). The fungal cell wall determines cell shape, maintains cell wall integrity and is recognized by the innate immune system. The cell walls of Candida spp. in general are composed of an inner core of chitin and β-1,3-glucan, which is covered by an outer layer of cell wall proteins, the majority of which are covalently linked to β-1,6-glucan by modified glycosylphosphatidylinositol (GPI) anchors (Gow et al., 2017). The cell wall is a dynamic structure which alters its composition in response to cell wall stress by upregulating genes involved in cell wall synthesis, in an attempt to restore the robustness of the cell wall (Walker et al., 2008). Treatment of C. albicans with caspofungin has been shown to lead to a compensatory increase in chitin content, in vitro and in vivo (Walker et al., 2008; Lee et al., 2012). This compensatory increase in chitin is not specific to C. albicans as C. tropicalis, C. parapsilosis, C. guilliermondii, and isolates of C. krusei also demonstrated an elevation in chitin content in response to caspofungin treatment (Walker et al., 2013). In addition, isolates of C. albicans, C. krusei, C. parapsilosis, and C. guilliermondii, which have increased chitin content are less susceptible to caspofungin (Walker et al., 2008, 2013). C. albicans cells with elevated chitin contents have also been shown to be less susceptible to caspofungin in a murine model of systemic infection (Lee et al., 2012). Putative GPI-modified cell wall proteins have been implicated in susceptibility to caspofungin as deletion of specific proteins leads to alterations in cell wall composition and subsequently to differences in susceptibility to caspofungin (Plaine et al., 2008). As a result of the cell wall remodeling that occurs in response to caspofungin treatment, chitin and β-1,3-glucan also become more exposed on the cell surface (Wheeler and Fink, 2006; Wheeler et al., 2008; Mora-Montes et al., 2011). The fungal cell wall plays an important role in immune recognition as it is the first point of contact between the host and pathogen. The main innate immune cells that are involved in the recognition of invading pathogens are neutrophils, monocytes and macrophages (Netea et al., 2008). Components of the cell wall act as pathogen associated molecular patterns (PAMPs), which are recognized by pattern recognition receptors (PRRs) on host cells (Brown and Gordon, 2001; Porcaro et al., 2003; Kohatsu et al., 2006; McGreal et al., 2006; Netea et al., 2006, 2008). The two main classes of PRRs are the Toll-like receptors (TLRs) and the C-type lectin receptors (CLRs). The TLRs recognize phospholipomannan and O-linked mannan, whereas the C-type lectin receptors recognize β-1,3-glucan and mannan (Stahl et al., 1978; Wileman et al., 1986; Jouault et al., 2003; McGreal et al., 2006; Netea et al., 2006, 2008; Sato et al., 2006; Gow et al., 2007; Taylor et al., 2007). The increased exposure of chitin and β-1,3-glucan on the cell surface of C. albicans, in response to caspofungin treatment, results in altered cytokine production by immune cells, indicating that remodeling of the cell wall influences interactions with host cells (Wheeler and Fink, 2006; Wheeler et al., 2008; Mora-Montes et al., 2011; Baltch et al., 2012a,b; Fidan et al., 2014). Caspofungin treatment of C. albicans cells, followed by UV inactivation led to increased recognition of fungal cells by the C-type lectin, Dectin-1, which in turn increased cytokine production (Wheeler and Fink, 2006; Wheeler et al., 2008). In contrast, increased exposure of chitin on the surface of C. albicans has been shown to result in reduced cytokine production (Mora-Montes et al., 2011). Naturally occurring variations in the cell walls of different C. albicans isolates influences the dependency on dectin-1 for recognition and clearance of fungal cells (Marakalala et al., 2013). In addition the role of dectin-1 in recognition of four different Candida species, with differences in their cell wall carbohydrate composition, also varies (Thompson et al., 2019). Because different Candida species vary in their ability to cause infection and vary in their cell wall composition, we aimed to perform a detailed comparison of the cell wall architectures of seven most prevalent Candida spp. and examine how their surface carbohydrates and proteomes change in response to caspofungin (CSF) treatment. In addition, the effect of caspofungin-induced cell wall changes of the different Candida species on the response of host immune cells was investigated.

Materials and Methods

Strains, Media, and Growth Conditions

The strains of each Candida species that were used in this study had been typed and their genomes sequenced, these strains are listed in Table 1. Strains were maintained on solid YPD medium [1% (w/v) yeast extract, 2% (w/v) mycological peptone, 2% (w/v) glucose, 2% (w/v) agar]. RPMI-1640 medium (Gibco, Paisley, UK) was used for drug susceptibility testing and for growing cultures for HPLC and proteomic analysis.
Table 1

Caspofungin susceptibilities of sequenced strains of different Candida species.

SpeciesStrain nameCaspofungin IC50 (μg/ml)References
Candida albicansSC53140.032(Gillum et al., 1984)
Candida dubliniensisCD360.064(Sullivan et al., 1995)
Candida glabrataATCC20010.064American Type Culture Collection
Candida tropicalisMYA-34040.125American Type Culture Collection
Candida lusitaniaeATCC427200.5American Type Culture Collection
Candida parapsilosisATCC220191American Type Culture Collection
Candida guilliermondiiATCC62608American Type Culture Collection

As determined by broth microdilution testing. The IC.

Caspofungin susceptibilities of sequenced strains of different Candida species. As determined by broth microdilution testing. The IC.

Preparation of FITC-Stained Candida spp

Staining of Candida spp. yeast cells with fluorescein isothiocyanate (FITC) was performed as previously described (Graham et al., 2006). Briefly, Candida spp. were grown in YPD in the presence or absence of an IC50 concentration of caspofungin (Walker et al., 2013) in YPD at 30°C for 6 h. Candida spp. cells were washed twice with PBS and stained for 10 min at room temperature in the dark with 1 mg/ml fluorescein isothiocyanate (FITC) (Sigma, Dorset, United Kingdom) in 0.05 M carbonate-bicarbonate buffer (pH 9.6) (BDH Chemicals, VWR International, Leicestershire, United Kingdom). Cells were then washed three times in 1x PBS to remove residual FITC and were resuspended in 1x PBS. FITC-stained 6x105 Candida spp. cells that had been pre-grown with or without IC50 caspofungin were then added to the macrophages at a multiplicity of infection (MOI) of 3 Candida spp. cells per macrophage, and incubated at 37°C for 4 h before visualization.

Phagocytosis and Cytokine Assays

Macrophage Cell Culture

J774.1 murine macrophages (European Collection of Cell Culture) were cultured in Dulbecco's modified Eagle's medium (DMEM; Lonza Group, Ltd., Braine-l'Alleud, Belgium), supplemented with 10% (vol/vol) fetal calf serum, 2% (wt/vol) penicillin and streptomycin antibiotics (Invitrogen, Ltd., Paisley, United Kingdom) in tissue culture flasks (Nalge Nunc, International, Hereford, United Kingdom) at 37°C and 5% (vol/vol) CO2. For phagocytosis assays, 2 × 105 J774.1 macrophages in 2 ml supplemented DMEM medium were seeded onto glass-based imaging dishes [Imaging dish CG 1.0; MACS Miltenyi Biotec (130-098-282), Surrey, UK] and incubated at 37°C with 5% CO2 for at least 2 h to allow for macrophage adherence to the dish. Immediately prior to experiments, DMEM medium was replaced with 2 ml pre-warmed supplemented CO2-independent medium (Gibco, Invitrogen, Paisley, UK) and cultures used immediately for phagocytosis assays. After 4 h of co-incubation 50 μl of supernatant was removed from phagocytosis assays to allow determination of TNFα production from J774 macrophages as a result of incubation with each Candida species. TNFα concentrations were determined using enzyme-linked immunosorbent assays (R&D Systems) according to the manufacturer's instructions.

Cell Wall Staining of Exposed Chitin and Glucan

Candida spp. yeast cells were grown in YPD in the presence or absence of an IC50 concentration of caspofungin in YPD at 30°C for 6 h. Cells were stained with 5 μg/ml Fc:Dectin1 protein to visualize exposed β-1,3-glucan, as previously described (52). Briefly, 1 × 106 cells/sample were blocked with FACS block (0.5% BSA, 5% HI-rabbit serum, 5 mM ETDA, 2 mM NaAzide in PBS) for 30 min. Cell pellets were harvested and washed 3 × with 1 ml FACS wash (0.5% BSA, 5 mM EDTA, 2 mM NaAzide in PBS) at 4°C. After washing, the cell pellet was resuspended in 100 μl of 5 μg/ml Fc:Dectin1 protein (diluted from stock in FACS block) and incubated for 1 h on ice. Cells were then washed 3 times with 1 ml FACS wash and resuspended in 200 μl FACS block plus 1/200 anti-human Fc+Alexa-488 and incubated for 45 min on ice. After incubation cells were washed three times with 1 ml FACS wash and fixed with 200 μl 1% formaldehyde. After fixing cells were also stained with 25 μg/ml Wheat Germ Agglutinin conjugated to Texas Red (WGA-TR). All samples were examined by DIC and fluorescence microscopy using a Zeiss Axioplan 2 microscope. Images were recorded digitally using the Openlab system (Openlab v 4.04, Improvision, Coventry, UK) and a Hamamatsu C4742- 95 digital camera (Hamamatsu Photonics, Hamamatsu, Hertfordshire, UK). In all experiments the exposure time for a series of fluorescence images was fixed so the intensity of fluorescence relative to a control was used as standard. Chitin and β-1,3-glucan exposure were measured by quantifying WGA-TR and Fc:Dectin1-488 fluorescence, respectively, of individual yeast cells (Walker et al., 2008). Mean fluorescence intensities were calculated for 50 individual cells of each Candida species, for each condition.

High-Pressure Freezing (HPF)-Transmission Electron Microscopy (TEM)

Candida spp. yeast cells were grown in YPD at 30°C for 6 h and HPF was carried out as described previously (Walker et al., 2010) with the following modifications. Briefly, samples were prepared by high-pressure freezing with an EMPACT2 high-pressure freezer and rapid transport system (Leica Microsystems Ltd., Milton Keynes, United Kingdom). After freezing, cells were freeze-substituted in substitution reagent (1% [wt/vol] OsO4 in acetone) with a Leica EMAFS2. Samples were then embedded in Epoxy resin and additional infiltration was provided under a vacuum at 60°C before embedding in Leica FSP specimen containers and polymerizing at 60°C for 48 h. Semithin survey sections, 0.5 μm thick, were stained with 1% toluidine blue to identify areas containing cells. Ultrathin sections (60 nm) were prepared with a Diatome diamond knife on a Leica UC6 ultramicrotome and stained with uranyl acetate and lead citrate for examination with a Philips CM10 transmission microscope (FEI UK Ltd., Cambridge, United Kingdom) and imaging with a Gatan Bioscan 792 (Gatan United Kingdom, Abingdon, United Kingdom). Image J was used to measure the thickness of the inner (chitin and glucan) and outer cell wall by averaging measurements for 30 cells, for each condition.

Antifungal Susceptibility Testing

CSF (Merck Research Laboratories, New Jersey, USA) minimum inhibitory concentrations were determined by broth micro-dilution testing using the CLSI guidelines M27-A3. Drug concentrations ranged from 0.016 to 16 μg/ml CSF. Exponentially grown cultures were diluted to 2 × 106 cells/ml in 2x RPMI-1640 and 100 μl of culture was added to each well. Plates were incubated for 24 h at 37°C. After incubation, optical densities were read in a VERSAmax tunable microplate reader (Molecular Devices, California, USA) at 405 nm.

HPLC Analysis of Cell Wall Composition

Cell walls were extracted as described previously (Mora-Montes et al., 2011). Briefly, each Candida species was grown in RPMI-1640 for 3 h at 37°C with shaking at 200 rpm. Each Candida species was then subsequently treated with a sub-MIC concentration of CSF (as determined from Table 1) for an additional 2 h, or grown without addition of drug for a further 2 h, as an untreated control. Cells were collected by centrifugation at 4,000 g for 5 min, washed once with chilled deionized water, resuspended in deionized water, and physically fractured with glass beads in a FastPrep machine (Qbiogene). The lysed cells were collected by centrifugation at 4,000 g for 5 min. The pellet containing the cell debris and walls was washed five times with 1 M NaCl, resuspended in extraction buffer (500 mM Tris-HCl buffer, pH 7.5, 2% [wt/vol] SDS, 0.3 M β-mercaptoethanol, and 1 mM EDTA), boiled at 100°C for 10 min, and freeze-dried. To quantify glucan, mannan, and chitin the cell walls were acid hydrolyzed as previously described (Lee et al., 2012). The hydrolyzed samples were analyzed by high-performance anion exchange chromatography with pulsed amperometric detection (HPAEC-PAD) in a carbohydrate analyzer system from Dionex (Surrey, United Kingdom) as described previously (Plaine et al., 2008). The total concentration of each cell wall component was expressed as μg per mg of dried cell wall which was determined by calibration from the standard curves of glucosamine, glucose, and mannose monomers, and converted to a percentage of the total cell wall.

Proteomic Analysis

Analysis of cell wall proteins was as described previously (Dutton et al., 2014). Candida species were grown with or without CSF as described for the HPLC analysis above. Briefly, 2 mg of freeze dried cell wall was mixed with 0.5 M ammonium bicarbonate in water containing 3 mM dithiothreitol and heated at 60°C for 20 min. Iodoacetamide (30 μl of 55 mM stock solution) was then added, and the suspension was incubated in the dark, at 25°C for 10 min. Following addition of 30 μl of 20 mg/ml trypsin, the suspension was incubated at 37°C for 14 h and centrifuged at 14,000 × g for 10 min. The supernatant was freeze-dried and extracted with 10% formic acid, and peptides were purified using ZipTip mC18 pipette tips (Millipore) and dissolved in 0.1% formic acid. Samples (3 μl) were injected into an LC-MS system which comprised an UltiMate 3000 LC instrument (Dionex Ltd., United Kingdom) fitted with a PepSwift monolithic poly(styrene-codivinylbenzene) (PS-DVB) column (200 μm inside diameter [i.d.] by 5 cm; Dionex) coupled to an HCTultra ion trap mass spectrometer (Bruker Daltonik GmbH, Bremen, Germany) fitted with a low-flow nebulizer in the electrospray ionization (ESI) source and controlled by HyStar software (version 4.0; Bruker Daltonik). Peptides were separated at a flow rate of 2 μl/min using a linear gradient of 0–40% acetonitrile-water-formic acid (80:20:0.04) (solvent B) in water-acetonitrile-formic acid (97:3:0.05) (solvent A) over 40 min, followed by a 1 min column wash in 90% solvent B and a 12-min equilibration step in solvent A. MS/MS data (scan range, m/z 100–2,200; averages 2) were acquired in positive data-dependent AutoMS(n) mode using the esquireControl software program (version 6.2; Bruker Daltonik). Up to three precursor ions were selected from the MS scan (range, m/z 300–1,500; averages 3) in each AutoMS(n) cycle. Precursors were actively excluded after being selected twice within a 1-min window, and singly charged ions were also excluded. Peptide peaks were detected (maximum of 9,999 compounds above an intensity threshold of 50,000) and deconvoluted automatically using Data Analysis software (version 3.4; Bruker Daltonik). Mass lists in the form of Mascot Generic Format (*. mgf) files were created automatically and used as inputs to Mascot MS/MS ion searches via a local Mascot server (version 2.2; Matrix Science, London, United Kingdom) with a database built from sequence files available from Candida Genome Database (32). The Search parameters used were the following: enzyme = trypsin; fixed modifications = carbamidomethyl (C); variable modifications = oxidation (M); mass values = monoisotopic; peptide mass tolerance = 1.5 Da; fragment mass tolerance = 0.5 Da; max missed cleavages = 1; instrument type = ESI-TRAP. Search results were displayed by Mascot after selection of the following parameters: standard scoring; require bold red; ion score or expect cutoff = 0.05.

Statistical Analyses

Results from independent replicate experiments are expressed as means ± SD. One-way ANOVA with a Dunnett's post-hoc test was used for statistical analysis. Significance was determined as p < 0.05.

Results

IC50 of Candida spp to Caspofungin

The susceptibility of each of the sequenced Candida spp. strains, used in this study, to CSF was determined following the CLSI-M27-A3 guidelines. C. albicans, C. dublinensis, C. glabrata, and C. tropicalis were the most susceptible to CSF (Table 1). The IC50 range for these susceptible species was between 0.032 and 0.064 μg/ml CSF (Table 1). C. lusitaniae and C. parapsilosis had CSF IC50 measurements of 0.5 and 1 μg/ml, respectively, which was classified as intermediate susceptibility and C. guilliermondii was resistant to CSF (Table 1). Therefore, the order of susceptibility to CSF from most susceptible to most resistant of the isolates of the Candida spp. tested here was: C. albicans > C. dubliniensis > C. glabrata > C. tropicalis > C. lusitaniae > C. parapsilosis > C. guilliermondii.

Candida Species Have Differences in the Ultrastructure of Their Cell Wall

Ultrastructural differences in the cell wall of each Candida species were investigated using high pressure freezing transmission electron microscopy (TEM) which conserves the fungal cell wall architecture. TEM analysis revealed that the inner core of the cell wall of C. glabrata (Figure 1A, v) and C. tropicalis (Figure 1A, ii) isolates was significantly thicker than the inner core of C. albicans isolate (Figure 1A, i; Figure 1B). In contrast to this the inner core of the C. guilliermondii cell wall (Figure 1A, vii) was significantly thinner, in comparison to C. albicans (Figure 1A, i; Figure 1B). Overall, the largest difference in the cell wall between the Candida species was in the outer fibrillar layer (Figure 1B). The variations in length of the outer fibrillar layer were classified as either long (>65 nm), intermediate (30–65 nm), or short (<30 nm) (Figure 1B). C. albicans and C. tropicalis had the longest outer fibrillar layers, followed by C. dubliniensis and C. lusitaniae which were classified as having intermediate fibril length (Figure 1B). C. glabrata, C. parapsilosis, and C. guilliermondii isolates had short outer fibrils on the cell surface, in comparison to the C. albicans isolate (Figure 1B).
Figure 1

The ultrastructure of the cell wall varies between Candida species. (A) TEMs of the cell wall of different Candida species: C. albicans (i), C. tropicalis (ii), C. dublinensis (iii), C. lusitaniae (iv), C. glabrata (v), C. parapsilosis (vi) and C. guilliermondii (vii). Scale bars are 100 nm. (B) The thickness of the inner cell wall (glucan and chitin) and outer fibrillar layer was determined from TEM pictures. Measurements from 30 cells that were sectioned so that cell wall thickness was even all around the cell periphery. Significant differences (*p < 0.05) compared to C. albicans. Error bars are SD (n = 30).

The ultrastructure of the cell wall varies between Candida species. (A) TEMs of the cell wall of different Candida species: C. albicans (i), C. tropicalis (ii), C. dublinensis (iii), C. lusitaniae (iv), C. glabrata (v), C. parapsilosis (vi) and C. guilliermondii (vii). Scale bars are 100 nm. (B) The thickness of the inner cell wall (glucan and chitin) and outer fibrillar layer was determined from TEM pictures. Measurements from 30 cells that were sectioned so that cell wall thickness was even all around the cell periphery. Significant differences (*p < 0.05) compared to C. albicans. Error bars are SD (n = 30).

Candida Species Have Species Specific GPI-Anchored Proteins Present on Their Cell Surface

To determine the differences in the cell wall proteome between the different Candida species, LC-MS/MS was used to identify which covalently attached, predicted GPI-modified proteins were present on the surface of each Candida species when they were cultured in RPMI-1640 medium (Table 2). Here we have annotated the proteins according to their C. albicans orthologs based on sequence similarity according to Candida Genome Database (Skrzypek et al., 2016). A core set of predicted cell wall proteins were identified in all species (Table 2). The hyphal specific protein, Hyr1, was uniquely detected in the cell wall of C. albicans, commensurate with it being a C. albicans-specific hyphal-associated protein and C. albicans will undergo filamentation in RPMI-1640 medium. GPI-anchored proteins that were identified specifically in the cell wall of C. dubliniensis included two Als proteins involved in adhesion and the secreted aspartyl protease, Sap9 (Table 2). A fungal-specific phospholipase and Pga59 orthologs were detected only on the cell surface of C. lusitaniae (Table 2). The cell wall of C. parapsilosis was found to contain orthologs of the yeast wall protein, Ywp1/Pga24, and Pga30, a protein of unknown function (Table 2).
Table 2

Candida species-specific detection of cell wall GPI-anchored proteins by LC/MS/MS proteomics.

Species specific detection of putative GPI-anchored proteinsa,b,c
C. albicansC. dubliniensisC. lusitaniaeC. parapsilosisC. tropicalisC. glabrataC. guilliermondii
Hyr1 (C1_13450W_A)Als4 (CD36_64610)Pga31 (CLUG_00164)Pga24/Ywp1 (CPAR2_806670)Pga24/Ywp1 (CTRG_01856)Epa6 (CAGL0C00110g)Pga24/Ywp1 (DEHA2A14366g)
Als2 (CD36_64800)Rbt1 (CLUG_03306)Pga30 (CPAR2_402000)Epa3 (CAGL0E06688g)
Sap9 (CD36_83850)Awp4 (CAGL0J12001g)

Proteins assigned common names according to their C. albicans orthologs (Butler et al., .

Detected in at least one of three biological replicate samples.

In addition the following proteins were detected in all samples: Ssr1 (C7_00860W_A), Pga4 (C5_05390C_A), Crh11 (C4_02900C_A).

Candida species-specific detection of cell wall GPI-anchored proteins by LC/MS/MS proteomics. Proteins assigned common names according to their C. albicans orthologs (Butler et al., . Detected in at least one of three biological replicate samples. In addition the following proteins were detected in all samples: Ssr1 (C7_00860W_A), Pga4 (C5_05390C_A), Crh11 (C4_02900C_A). Caspofungin treatment has been previously shown to alter cell wall architecture and increases chitin production in C. albicans, C. tropicalis, C. krusei, C. parapsilosis, and C. guilliermondii (9). The effect of CSF treatment on the cell wall proteome of each Candida species was also investigated by treating each Candida spp. with their IC50 concentration of caspofungin (Table 3). Certain proteins were detected only at the cell surface in response to CSF treatment in addition to the proteins listed that are found on the surface of untreated cells. The proteins expressed in response to caspofungin varied between the different Candida spp. Orthologs of the transglycosidase, Utr2, were detected on the cell surface of the majority of Candida species in response to CSF treatment with the exception of C. glabrata (Table 3). Orthologs of Pga31, a GPI-anchored protein of unknown function was detected on the surface of the species that were most sensitive to CSF, such as C. albicans, C. dublinensis, and C. tropicalis in response to CSF treatment (Table 3). A protein related to Pga30, a member of the same family as Pga31 was detected in the cell wall of C. guilliermondii treated with CSF. C. lusitaniae and C. parapsilosis, which have intermediate susceptibility to CSF, were found to have Als-like proteins on their cell surface in response to CSF treatment (Table 3).
Table 3

Caspofungin treatment specific proteins in different Candida species in RPMI-1640 medium.

SpeciesCell wall proteins specific to CSF-treated cellsa,b,c
C. albicansUtr2 (C3_01730C_A)Pga31 (C4_04080C_A)Ecm33 (C1_03190C_A)Rbt1 (C4_03520C_A)Pga29 (C4_04050C_A)
C. dubliniensisUtr2 (CD36_81610)Pga31 (CD36_43780)Phr2 (CD36_00220)
C. lusitaniaeUtr2 (CLUG_02005)Pga62 (CLUG_00242)Als1Phr1 (CLUG_01043)Pga24 (CLUG_00242)
C. parapsilosisUtr2 (CPAR2_503190)Als1
C. tropicalisUtr2 (CTRG_02140)Pga31 (CTRG_00350)Ecm33 (CTRG_00105)
C. glabrataPir3 (CAGL0M08492g)Crh1 (CAGL0G09449g)
C. guilliermondiiUtr2 (PGUG_00573)Pga30 (PGUG_01942)Plb5 (PGUG_01288)

Proteins assigned common names according to their C. albicans orthologs (Butler et al., .

Detected in at least one of three biological replicate samples.

These proteins were not detected in the cell walls of untreated cultures.

Caspofungin treatment specific proteins in different Candida species in RPMI-1640 medium. Proteins assigned common names according to their C. albicans orthologs (Butler et al., . Detected in at least one of three biological replicate samples. These proteins were not detected in the cell walls of untreated cultures.

Cell Wall Composition of Different Candida Species in the Presence or Absence of CSF

The carbohydrate composition of the cell walls of the different Candida spp., in the presence or absence of an IC50 concentration of caspofungin, was determined by acid hydrolysis of isolated cell walls and analysis by high-performance liquid chromatography. C. tropicalis had substantially higher chitin content than C. albicans, whereas C. glabrata and C. guilliermondii had significantly less chitin compared to C. albicans (Table 4). The majority of Candida spp. had comparable levels of glucan in the cell wall, with the exception of C. tropicalis, which had significantly reduced glucan compared to C. albicans and C. glabrata, which had a higher glucan content (Table 4). The quantity of mannan in the cell wall was significantly reduced in C. glabrata, C. parapsilosis, and C. guilliermondii compared to C. albicans (Table 4) in agreement with the TEM analysis which suggested these species have shorter mannan fibrils on their outer surfaces. In most cases treatment with CSF resulted in an increase in chitin content, with the exception of C. glabrata and C. parapsilosis (Table 4). As expected all Candida spp. isolates tested had a reduction in β-1,3-glucan in response to CSF treatment. Exposure to an IC50 concentration of CSF led to a significant increase in mannan content in all Candida spp., with the exception of C. tropicalis and C. dublinensis isolates (Table 4).
Table 4

Quantification of the components of the cell wall of Candida species, with and without caspofungin treatment ,,[*][#].

Candida spp.% Dried cell wall
ChitinGlucanMannan
C. albicans4 ± 0.2 (100%)66 ± 3 (100%)30 ± 2 (100%)
C. albicans + CSFc8 ± 1[#] (200%)43 ± 5[#] (65%)49 ± 3[#] (163%)
C. tropicalis5 ± 0.5* (100%)54 ± 2* (100%)41 ± 6 (100%)
C. tropicalis + CSF12 ± 4 (240%)[#]40 ± 7 (74%)[#]49 ± 2 (120%)
C. dubliniensis5 ± 0.8 (100%)63 ± 4 (100%)32 ± 1 (100%)
C. dubliniensis + CSF13 ± 2[#] (260%)49 ± 6[#] (78%)38 ± 3 (119%)
C. lusitaniae4 ± 0.1 (100%)70 ± 8 (100%)26 ± 2 (100%)
C. lusitaniae + CSF9 ± 3[#] (225%)53 ± 11[#] (76%)38 ± 3[#] (146%)
C. glabrata2 ± 0.1* (100%)81 ± 5* (100%)17 ± 4* (100%)
C. glabrata + CSF1 ± 0.2 (50%)67 ± 3[#] (83%)32 ± 2[#] (188%)
C. parapsilosis7 ± 5 (100%)75 ± 4 (100%)18 ± 3* (100%)
C. parapsilosis +CSF8 ± 3 (114%)62 ± 2[#] (83%)30 ± 6[#] (167%)
C. guilliermondii2 ± 1* (100%)79 ± 6 (100%)19 ± 2* (100%)
C. guilliermondii + CSF6 ± 0.5[#] (300%)59 ± 8[#] (75%)36 ± 5[#] (189%)

Cell walls were acid hydrolyzed and released monosaccharide was detected.

Results are expressed as a % of dried cell wall of the untreated data ± SD. n = 3 biological replicates. For + CSF samples % in brackets is relative to untreated samples which were set as 100%.

IC.

Significantly different compared to untreated cells of C. albicans (P = 0.05).

Significantly different compared to untreated cells of the same species (P = 0.05).

Quantification of the components of the cell wall of Candida species, with and without caspofungin treatment ,,[*][#]. Cell walls were acid hydrolyzed and released monosaccharide was detected. Results are expressed as a % of dried cell wall of the untreated data ± SD. n = 3 biological replicates. For + CSF samples % in brackets is relative to untreated samples which were set as 100%. IC. Significantly different compared to untreated cells of C. albicans (P = 0.05). Significantly different compared to untreated cells of the same species (P = 0.05).

Candida Species Have Differences in Surface Exposure of Chitin and Glucan in Response to CSF Treatment

Exposure of chitin and glucan on the cell surface is known to influence the immune recognition of fungal cells (Wheeler and Fink, 2006; Wheeler et al., 2008; Mora-Montes et al., 2011). Fluorescent staining was used to determine whether the differences in outer fibril length between the Candida species isolates correlated with variations in exposure of chitin and β-1,3-glucan on the cell surface. The exposure of chitin was determined using 25 μg/ml Wheat Germ Agglutinin-Texas Red (WGA-TR) and exposed β-1,3-glucan was stained with 5 μg/ml Fc:Dectin1- Alexa 488 (Table 5, Supplementary Figure 1). The exposure of chitin and β-1,3-glucan, after treatment with an IC50 concentration of CSF for 6 h, was determined for each Candida species isolate. Exposure of β-1,3-glucan was significantly higher on the surface of untreated C. glabrata and C. guilliermondii compared to C. albicans (Table 5). Treatment with CSF, at the IC50, resulted in increased exposure of β-1,3-glucan on the surface of C. albicans, C. tropicalis, C. dubliniensis, C. lusitaniae, and C. guilliermondii (Table 5). However, CSF treatment had no effect on the exposure of β-1,3-glucan of C. glabrata and C. parapsilosis (Table 5). Measurement of exposed chitin on the cell surface determined that the C. glabrata isolate had less chitin exposed on the outer surface compared to C. albicans isolate (Table 5). Treatment of C. albicans, C. tropicalis, C. dubliniensis, C. lusitaniae, and C. guilliermondii with CSF resulted in increased detection of chitin on the cell surface (Table 5). The exception to this was C. glabrata and C. parapsilosis which had no change in exposure of chitin, in response to CSF treatment (Table 5).
Table 5

Quantification of the exposure of β-1,3-glucan and chitin of Candida species, with and without caspofungin treatment.

Candida speciesGlucan exposure (mean fluorescence intensity)Chitin exposure (mean fluorescence intensity)
No treatmentCaspofungin treatmentNo treatmentCaspofungin treatment
C. albicans179 ± 20450 ± 34#167 ± 17488 ± 51#
C. dubliniensis211 ± 14374 ± 52#160 ± 26404 ± 40#
C. glabrata273 ± 21*257 ± 3989 ± 18*79 ± 20
C. tropicalis185 ± 41607 ± 66#178 ± 22516 ± 54#
C. lusitaniae171 ± 29468 ± 49#159 ± 31438 ± 35#
C. parapsilosis201 ± 13189 ± 30172 ± 28202 ± 45
C. guilliermondii263 ± 36*537 ± 72#160 ± 29445 ± 49#

The average relative β-1,3-glucan and chitin contents of individual cells from different Candida species were determined by measuring the intensity of Fc:Dectin1–Alexa488 and WGA-Texas Red fluorescence. Measurements were made on untreated control cultures and after growth with caspofungin at the specific IC.

Quantification of the exposure of β-1,3-glucan and chitin of Candida species, with and without caspofungin treatment. The average relative β-1,3-glucan and chitin contents of individual cells from different Candida species were determined by measuring the intensity of Fc:Dectin1–Alexa488 and WGA-Texas Red fluorescence. Measurements were made on untreated control cultures and after growth with caspofungin at the specific IC.

Relationship Between Phagocytosis and Exposure of Chitin and Glucan

To determine the effect of exposure of chitin and glucan on phagocytosis, the uptake of isolates of each Candida species by J774 macrophages was determined. The yeasts were cultured with and without sub-MIC CSF treatment and phagocytosis correlated to the exposure of chitin and β-1,3-glucan on the cell surface (Figure 2, Supplementary Table 1). The majority of Candida species had low levels of chitin and β-1,3-glucan exposed naturally on the cell surface, under the growth conditions used (Figure 2A). The exception was C. glabrata and C. guilliermondii which had significantly more β-1,3-glucan exposed on the cell surface, compared to C. albicans, which correlated with these Candida species having the highest phagocytosis by J774 macrophages (Figure 2A). To determine the effect of altered exposure of β-1,3-glucan and chitin, the phagocytosis of CSF-treated cells was also measured (Figure 2B). In all cases the combined increase in exposure of chitin and β-1,3-glucan, in CSF-treated cells, resulted in a significant decrease in phagocytosis by macrophages (Figure 2B). Treatment of C. glabrata and C. parapsilosis with CSF had little effect on the exposure of the outer cell wall components and consequently there was no significant change in their phagocytosis by macrophages (Figure 2B). Pearson Correlation analysis demonstrated that there was a positive correlation between glucan exposure and chitin exposure and caspofungin treatment [r(12) = 0.703, p = 0.005; r(12) = 0.699, p = 0.005 respectively] but a negative correlation between % phagocytosis and caspofungin treatment [r(12) = −0.763, p = 0.002].
Figure 2

Correlation between exposure of chitin and glucan on the cell surface of Candida species and phagocytosis by J774 macrophages. The values for exposure of chitin and β-1,3-glucan were taken from Table 5. Phagocytosis of Candida spp. by macrophages was determined by fluorescence microscopy. All cells were stained with 10 μg/ml FITC prior to exposure to macrophages. FITC-stained cells were exposed to J774 macrophages for 1 h, after which non-phagocytosed cells were stained with 25 μg/ml CFW. The number of macrophages which had phagocytosed Candida cells were then counted (n = 300). (A) Untreated Candida spp. cells. (B) CSF treated Candida cells. Black shapes = chitin (WGA-TR), gray shapes = glucan (Fc:dectin1-alexa488).

Correlation between exposure of chitin and glucan on the cell surface of Candida species and phagocytosis by J774 macrophages. The values for exposure of chitin and β-1,3-glucan were taken from Table 5. Phagocytosis of Candida spp. by macrophages was determined by fluorescence microscopy. All cells were stained with 10 μg/ml FITC prior to exposure to macrophages. FITC-stained cells were exposed to J774 macrophages for 1 h, after which non-phagocytosed cells were stained with 25 μg/ml CFW. The number of macrophages which had phagocytosed Candida cells were then counted (n = 300). (A) Untreated Candida spp. cells. (B) CSF treated Candida cells. Black shapes = chitin (WGA-TR), gray shapes = glucan (Fc:dectin1-alexa488).

Cytokine Production Varies Between Candida Species and Is Reduced in Response to CSF Treatment

Increased exposure of β-1,3-glucan has previously been shown to stimulate cytokine production whereas increased exposure of chitin has been shown to result in a decrease in cytokine production (Wheeler and Fink, 2006; Wheeler et al., 2008; Mora-Montes et al., 2011). To determine the cytokine production stimulated by the different Candida species, TNFα production was measured when untreated live cells of each Candida species were exposed to J774 macrophages for 4 h (Figure 3). Live cells of C. albicans and C. dubliniensis stimulated the highest levels of TNFα production (Figure 3). The other Candida species all stimulated very low levels of TNFα (Figure 3), which remained unchanged even after 24 h (data not shown). Treatment with an IC50 concentration of CSF, specific to each Candida species, led to a significant decrease in TNFα production in C. albicans and C. dubliniensis, compared to untreated cells (Figure 3). Treatment with CSF had no effect on TNFα production in the other Candida species isolates, with the exception of the C. tropicalis isolate which had a significant increase in TNFα production compared to untreated cells (Figure 3). C. tropicalis also had the highest level of surface-exposed β(1,3)-glucan when treated with CSF.
Figure 3

Candida species stimulate different immune responses. Live cells of each Candida species, which had been grown with or without an IC50 concentration of caspofungin for 6 h, were exposed to J774 macrophages for 4 h. After 4 h of co-incubation, supernatants were collected and cytokine production was measured. Significant differences (#p < 0.05) compared to C. albicans. Significant differences (*p < 0.05) compared to untreated cells of the same species. Error bars are SD (n = 3).

Candida species stimulate different immune responses. Live cells of each Candida species, which had been grown with or without an IC50 concentration of caspofungin for 6 h, were exposed to J774 macrophages for 4 h. After 4 h of co-incubation, supernatants were collected and cytokine production was measured. Significant differences (#p < 0.05) compared to C. albicans. Significant differences (*p < 0.05) compared to untreated cells of the same species. Error bars are SD (n = 3).

Discussion

This study aimed to directly compare the structure and composition of the cell walls of different Candida species, examine how the cell wall was altered in response to caspofungin treatment and assess how this impacted on fungal: murine macrophage interactions. We demonstrated that the length of the outer fibrillar layer varied between the species isolates tested and that, in most cases, reduced fibril length correlated with increased exposure of β-1,3-glucan on the cell surface. C. glabrata and C. guilliermondii, which had naturally more β-1,3-glucan exposed on the cell surface, were phagocytosed more efficiently by J774 macrophages. This is in agreement with a previous study that showed that in a mixed population of C. albicans and C. glabrata cells, C. glabrata is preferentially phagocytosed over C. albicans (Keppler-Ross et al., 2010). Similar to our observations, Estrada-Mata et al. (2016) also demonstrated that C. parapsilosis had less mannan content but more β-1,3-glucan exposed on the surface compared to C. albicans which correlated with an increase in cytokine production by human PBMCs (Estrada-Mata et al., 2016). Dectin-1 has been shown to play an important role in recognition of C. parapsilosis by human PBMCs (Toth et al., 2013). In our study C. parapsilosis induced little cytokine production from J774 macrophages at 4 h, but differences in the source of immune cells and the time that Candida cells were exposed to immune cells before performing the ELISAs may account for these differences. There were also notable differences in the cell wall proteins that reside on the surface of the different Candida species, for example, the GPI-anchored proteins, Epa3, Epa6, and Awp4, were identified specifically on the cell wall of C. glabrata under the growth conditions tested. These are known to be adhesion proteins in C. glabrata which are associated with biofilm formation (de Groot et al., 2008; Kraneveld et al., 2011). The presence of cell wall proteins on the cell surface of C. glabrata, C. parapsilosis, and C. tropicalis has been shown to be dependent on the growth conditions tested (Karkowska-Kuleta et al., 2019). Treatment with CSF is known to result in a compensatory increase in cell wall chitin levels and result in increased exposure of chitin and β-1,3-glucan on the surface of C. albicans cells (Wheeler and Fink, 2006; Walker et al., 2008, 2013; Wheeler et al., 2008; Mora-Montes et al., 2011). All of the Candida species isolates tested, with the exception of C. glabrata and C. parapsilosis isolates, demonstrated a compensatory increase in cell wall chitin content in response to CSF treatment. Likewise, treatment with CSF also resulted in an increase in exposure of chitin and β-1,3-glucan on the cell surface for the majority of species tested. Notable exceptions were C. glabrata and C. parapsilosis with no changes in glucan exposure in response to caspofungin treatment. This increase in exposure of the inner cell wall polysaccharides, did not increase the number of macrophages that had engulfed the fungal cells in fact caspofungin treatment resulted in a reduction in % phagocytosis. The majority of live Candida spp. cells stimulated low levels of TNFα production. In comparison the C. albicans and C. dublinensis isolates stimulated elevated levels of TNFα but these levels were significantly reduced when macrophages were exposed to the same isolates after caspofungin treatment. A notable exception to this trend was CSF-treated C. tropicalis isolate which stimulated significantly elevated TNFα production compared to untreated cells attaining a level comparable to C. albicans and C. dublinensis. C. tropicalis had the highest level of Fc-dectin1-Alex488 staining with and without caspofungin treatment. These findings suggested that the immune stimulatory properties of the different Candida species is not solely dependent upon β-1,3-glucan exposure and recognition by Dectin-1 and other factors may come into play (Wagener et al., 2014). Recently, treatment with either fragments of chitin or β-1,3-glucan from Aspergillus fumigatus were shown to stimulate production of TNFα. In addition, combined treatment with both chitin and β-1,3-glucan resulted in a synergistic increase in TNFα production (Dubey et al., 2014). This is in contrast with the findings here where other changes at the cell surface including increased chitin exposure appeared to override any stimulation of the immune response elicited by glucan exposure. The differences in stimulation of the immune response may be due to variations in size of the cell wall polysaccharides and the way the polymer is presented to immune cells. Small particles of chitin are known to illicit a greater cytokine response compared to larger chitin fragments (Da Silva et al., 2009). Likewise, differences in polysaccharide structure may influence the immune response. The chitin microfibrils of A. fumigatus and C. albicans may have a different architecture, which could influence the immune response (Gow and Gooday, 1983; Lenardon et al., 2007). Recently, hyphal β-1,3-glucan of C. albicans was found to have a unique cyclical structure that is absent in β-1,3-glucan from the yeast form (Lowman et al., 2014). Compared to β-1,3-glucan from yeast cells, hyphal glucan was shown to induce an immune response in macrophages and human peripheral blood mononuclear cells through a Dectin-1-dependent mechanism. In addition CSF treatment has also been shown to not only effect β-1,3-glucan exposure but also its nano-structure with the density of dectin-1 binding sites increasing leading to increased phagocytosis by dendritic cells (Lin et al., 2016). To dissect further whether glucan and/or chitin plays the main role in caspofungin-mediated dampening of the immune response, it would be interesting to evaluate the effect of blocking receptors of both polysaccharides on interaction with macrophages. Another consideration is that the change in GPI-modified proteins on the cell surface, in response to CSF treatment, may also influence the interaction with immune cells. For example, the transglycosidase, Utr2, was detected on the surface of the majority of Candida species in response to CSF treatment. Utr2 is involved in crosslinking chitin and β-1,3-glucan and forms part of a compensatory mechanism activated in response to cell weakening induced by echinocandin treatment (Pardini et al., 2006). A C. albicans utr2Δ mutant was found to have the same susceptibility to micafungin as the wild type (Alberti-Segui et al., 2004). Deletion of UTR2 in C. albicans resulted in attenuated virulence in a mouse model of systemic candidiasis. Despite this attenuation in virulence the fungal burdens from the kidneys of mice infected with the utr2Δ mutant were comparable to that of mice infected with wild-type C. albicans. This suggests that in the absence of UTR2, cells do not elicit the same inflammatory response as wild-type cells and enables the utr2Δ mutant to be tolerated by the host, leading to survival of the infected mice (Pardini et al., 2006). Therefore, the increased abundance of Utr2 on the cell surface in response to caspofungin treatment may also contribute to altered interactions with host cells. Candida guilliermondii and C. parapsilosis are known to be intrinsically less sensitive to the echinocandins. Both species had thin walls and their cell wall proteomes differed from CSF-susceptible species. Pga24/Ywp1 orthologs were detected on their cell surfaces when grown on RPMI-1640 medium. In C. albicans Pga24 is associated with the yeast cell wall (Granger et al., 2005) and here was not detected when C. albicans was grown on RPMI-1640 medium. Mutation of PGA24 did not alter echinocandin susceptibility of C. albicans (Plaine et al., 2008). The role of this surface protein in echinocandin susceptibility of C. guilliermondii and C. parapsilosis remains to be determined. The ability of live cells of each isolate of the different Candida species to stimulate cytokine production varied significantly (Figure 3). C. albicans and C. dubliniensis isolates, tested here, elicited the highest production of TNFα. In contrast to this the other isolates representing the different Candida species stimulated negligible levels of TNFα when exposed to J774 macrophages for 4 h. Previous work has demonstrated that C. parapsilosis, C. tropicalis, C. lusitaniae, and C. guilliermondii in addition to C. albicans and C. dubliniensis, stimulated production of TNFα from murine peritoneal macrophages and human PBMCs after 24 h (Aybay and Imir, 1996; Navarro-Arias et al., 2019). The most likely reason for the difference observed at the 4 h time point is that C. albicans and C. dubliniensis are the only two species which form true hyphae and were capable of germinating within macrophages, and consequently escaping from macrophages, faster than any of the other Candida species. For example, C. glabrata yeast cells have been shown to replicate within macrophages for up to 3 days before causing lysis of the macrophage (Seider et al., 2011). Therefore, the low levels of cytokine production that have been observed as a result of exposure of macrophages to live C. glabrata is thought to be due to C. glabrata evading host defenses by hiding within immune cells (Seider et al., 2011, 2014; Brunke et al., 2014). However, it is possible for C. glabrata to filament under certain conditions. Prolonged exposure of C. glabrata to macrophages led to filamentous growth which was a result of a point mutation in CHS2 (Lewis et al., 2013). Treatment of C. albicans and C. dubliniensis with CSF resulted in a decrease in production of TNFα and reduced phagocytosis by macrophages. Exposure of C. albicans to caspofungin has previously been shown to reduce cytokine production in both live and heat killed C. albicans cells, as a result of increased exposure of chitin on the cell surface (Mora-Montes et al., 2011). Here we examined caspofungin induced changes at the cell surface of representative isolates of different Candida species. We detected drug-induced changes in the repertoire of covalently attached surface proteins and alterations in the exposure of cell wall carbohydrates of contributing to their recognition by J774 macrophages. The cell surface is highly variable both between and within species and so these investigations should be expanded to a wider range of isolates of the different species to determine the extent of cell surface variability and how it impacts on host interactions and drug susceptibility.

Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation, to any qualified researcher.

Author Contributions

LW and CM contributed to acquisition, analysis, and interpretation of data for the work. All authors contributed to the design of the work and approved the submitted and final version.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
  62 in total

1.  Immune recognition. A new receptor for beta-glucans.

Authors:  G D Brown; S Gordon
Journal:  Nature       Date:  2001-09-06       Impact factor: 49.962

2.  Dectin-2 is a pattern recognition receptor for fungi that couples with the Fc receptor gamma chain to induce innate immune responses.

Authors:  Kota Sato; Xiao-li Yang; Tatsuo Yudate; Jin-Sung Chung; Jianming Wu; Kate Luby-Phelps; Robert P Kimberly; David Underhill; Ponciano D Cruz; Kiyoshi Ariizumi
Journal:  J Biol Chem       Date:  2006-10-18       Impact factor: 5.157

3.  Mannose receptor contribution to Candida albicans phagocytosis by murine E-clone J774 macrophages.

Authors:  Isabelle Porcaro; Michel Vidal; Sylvie Jouvert; Philip D Stahl; Jean Giaimis
Journal:  J Leukoc Biol       Date:  2003-08       Impact factor: 4.962

4.  Isolation of the Candida albicans gene for orotidine-5'-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations.

Authors:  A M Gillum; E Y Tsay; D R Kirsch
Journal:  Mol Gen Genet       Date:  1984

5.  Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors.

Authors:  Mihai G Netea; Neil A R Gow; Carol A Munro; Steven Bates; Claire Collins; Gerben Ferwerda; Richard P Hobson; Gwyneth Bertram; H Bleddyn Hughes; Trees Jansen; Liesbeth Jacobs; Ed T Buurman; Karlijn Gijzen; David L Williams; Ruurd Torensma; Alistair McKinnon; Donna M MacCallum; Frank C Odds; Jos W M Van der Meer; Alistair J P Brown; Bart Jan Kullberg
Journal:  J Clin Invest       Date:  2006-05-18       Impact factor: 14.808

6.  Differential recognition of Candida tropicalis, Candida guilliermondii, Candida krusei, and Candida auris by human innate immune cells.

Authors:  María J Navarro-Arias; Marco J Hernández-Chávez; Laura C García-Carnero; Diana G Amezcua-Hernández; Nancy E Lozoya-Pérez; Eine Estrada-Mata; Iván Martínez-Duncker; Bernardo Franco; Héctor M Mora-Montes
Journal:  Infect Drug Resist       Date:  2019-04-08       Impact factor: 4.003

7.  Evolution of pathogenicity and sexual reproduction in eight Candida genomes.

Authors:  Geraldine Butler; Matthew D Rasmussen; Michael F Lin; Manuel A S Santos; Sharadha Sakthikumar; Carol A Munro; Esther Rheinbay; Manfred Grabherr; Anja Forche; Jennifer L Reedy; Ino Agrafioti; Martha B Arnaud; Steven Bates; Alistair J P Brown; Sascha Brunke; Maria C Costanzo; David A Fitzpatrick; Piet W J de Groot; David Harris; Lois L Hoyer; Bernhard Hube; Frans M Klis; Chinnappa Kodira; Nicola Lennard; Mary E Logue; Ronny Martin; Aaron M Neiman; Elissavet Nikolaou; Michael A Quail; Janet Quinn; Maria C Santos; Florian F Schmitzberger; Gavin Sherlock; Prachi Shah; Kevin A T Silverstein; Marek S Skrzypek; David Soll; Rodney Staggs; Ian Stansfield; Michael P H Stumpf; Peter E Sudbery; Thyagarajan Srikantha; Qiandong Zeng; Judith Berman; Matthew Berriman; Joseph Heitman; Neil A R Gow; Michael C Lorenz; Bruce W Birren; Manolis Kellis; Christina A Cuomo
Journal:  Nature       Date:  2009-06-04       Impact factor: 49.962

8.  Differential adaptation of Candida albicans in vivo modulates immune recognition by dectin-1.

Authors:  Mohlopheni J Marakalala; Simon Vautier; Joanna Potrykus; Louise A Walker; Kelly M Shepardson; Alex Hopke; Hector M Mora-Montes; Ann Kerrigan; Mihai G Netea; Graeme I Murray; Donna M Maccallum; Robert Wheeler; Carol A Munro; Neil A R Gow; Robert A Cramer; Alistair J P Brown; Gordon D Brown
Journal:  PLoS Pathog       Date:  2013-04-18       Impact factor: 6.823

9.  Fungal chitin dampens inflammation through IL-10 induction mediated by NOD2 and TLR9 activation.

Authors:  Jeanette Wagener; R K Subbarao Malireddi; Megan D Lenardon; Martin Köberle; Simon Vautier; Donna M MacCallum; Tilo Biedermann; Martin Schaller; Mihai G Netea; Thirumala-Devi Kanneganti; Gordon D Brown; Alistair J P Brown; Neil A R Gow
Journal:  PLoS Pathog       Date:  2014-04-10       Impact factor: 6.823

10.  O-mannosylation in Candida albicans enables development of interkingdom biofilm communities.

Authors:  Lindsay C Dutton; Angela H Nobbs; Katy Jepson; Mark A Jepson; M Margaret Vickerman; Sami Aqeel Alawfi; Carol A Munro; Richard J Lamont; Howard F Jenkinson
Journal:  mBio       Date:  2014-04-15       Impact factor: 7.867

View more
  15 in total

1.  Antimicrobial Mechanisms of Enterocin CHQS Against Candida albicans.

Authors:  Qi Wang; Lei Pan; Ye Han; Zhijiang Zhou
Journal:  Curr Microbiol       Date:  2022-05-13       Impact factor: 2.188

2.  Stimulating fungal cell wall integrity by exogenous β-glucanase to improve the production of fungal natural products.

Authors:  Tingan Zhou; Shiyu Yu; Huibin Xu; Huiling Liu; Yijian Rao
Journal:  Appl Microbiol Biotechnol       Date:  2022-10-14       Impact factor: 5.560

Review 3.  Caspofungin resistance in Candida albicans: genetic factors and synergistic compounds for combination therapies.

Authors:  Francine Perrine-Walker
Journal:  Braz J Microbiol       Date:  2022-03-29       Impact factor: 2.214

4.  Biomarkers of caspofungin resistance in Candida albicans isolates: A proteomic approach.

Authors:  Giuseppe Buda De Cesare; Ahmed Hafez; David Stead; Carlos Llorens; Carol A Munro
Journal:  Virulence       Date:  2022-12       Impact factor: 5.428

5.  Current and promising pharmacotherapeutic options for candidiasis.

Authors:  Liliana Scorzoni; Beth Burgwyn Fuchs; Juliana Campos Junqueira; Eleftherios Mylonakis
Journal:  Expert Opin Pharmacother       Date:  2021-02-04       Impact factor: 3.889

6.  Replicative Aging Remodels the Cell Wall and Is Associated with Increased Intracellular Trafficking in Human Pathogenic Yeasts.

Authors:  Vanessa K A Silva; Somanon Bhattacharya; Natalia Kronbauer Oliveira; Anne G Savitt; Daniel Zamith-Miranda; Joshua D Nosanchuk; Bettina C Fries
Journal:  mBio       Date:  2022-02-15       Impact factor: 7.867

7.  Synergistic Antifungal Activity of Chitosan with Fluconazole against Candida albicans, Candida tropicalis, and Fluconazole-Resistant Strains.

Authors:  Wei-Hsuan Lo; Fu-Sheng Deng; Chih-Jung Chang; Ching-Hsuan Lin
Journal:  Molecules       Date:  2020-11-03       Impact factor: 4.411

8.  Antifungal-Loaded Calcium Sulfate Beads as a Potential Therapeutic in Combating Candida auris.

Authors:  Mark C Butcher; Jason L Brown; Donald Hansom; Rebecca Wilson-Van Os; Craig Delury; Phillip A Laycock; Gordon Ramage
Journal:  Antimicrob Agents Chemother       Date:  2021-10-25       Impact factor: 5.191

9.  Antifungal Carvacrol Loaded Chitosan Nanoparticles.

Authors:  Alberto Vitali; Annarita Stringaro; Marisa Colone; Alexandra Muntiu; Letizia Angiolella
Journal:  Antibiotics (Basel)       Date:  2021-12-22

10.  Chitin-rich heteroglycan from Sporothrix schenckii sensu stricto potentiates fungal clearance in a mouse model of sporotrichosis and promotes macrophages phagocytosis.

Authors:  Lilin Huang; Jing Zhang; Weian Du; Zixian Liang; Meirong Li; Rong Wu; Sanmei Chen; Xuchu Hu; Huaiqiu Huang
Journal:  BMC Microbiol       Date:  2021-06-25       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.